Results 191 to 200 of about 5,649,103 (354)

NORA research [PDF]

open access: yes
"Public awareness of the potential for healthcare to actually be the source of harm to patients through exposure to infectious agents, unintended error or known side effects of hazardous treatments has spawned a highly visible 'patient safety' movement ...

core  

Bilateral Prophylactic and Contralateral Risk‐Reducing Mastectomy in Women With Germline CDH1 Pathogenic or Likely‐Pathogenic Variants

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Bilateral prophylactic mastectomy (BPM) or contralateral risk‐reducing mastectomy (CRRM) are considered in CDH1 carriers as a strategy to reduce lobular breast cancer (LBC) risk in women. In this study we aimed to evaluate the overall number of these procedures reported in literature.
Giovanni Corso   +13 more
wiley   +1 more source

JAK Inhibitors in Psoriatic–Atopic Dermatitis Overlap: A Four‑Case Series

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Overlap between psoriasis and atopic dermatitis (AD) poses diagnostic and therapeutic challenges; monoclonal antibodies targeting a single axis may improve one component while worsening the other [1]. Janus kinase (JAK) inhibitors act pleiotropically and may provide simultaneous control of psoriatic and eczematous inflammation [2].
Eleonora Bongiovanni   +6 more
wiley   +1 more source

Sustained chlorhexidine susceptibility in clinical MRSA isolates despite recent exposure. [PDF]

open access: yesJAC Antimicrob Resist
Morello N   +6 more
europepmc   +1 more source

Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Introduction Alopecia areata (AA) is an autoimmune disease characterized by non‐scarring hair loss of the scalp and/or body, with an unpredictable and variable clinical course. Its etiology is not entirely understood, although evidence suggests that environmental, immunological, and genetic factors contribute to disease development.
Marco Rubatto   +7 more
wiley   +1 more source

114 CASE REPORT: SODIUM BROMATE, A SILENT NEPHROTOXIN

open access: yesKidney International Reports, 2017
D.Y. Mah, W.S. Cheong, S.Y. Tay
doaj   +1 more source

Home - About - Disclaimer - Privacy